Conversely, Quintela-Fandino et al. concluded that the accumulation of polymorphic variants including XRCC1 (Arg399Gln) predicts a favorable clinical outcome among patients with advanced head and neck squamous cell carcinoma (HR = 2.94, P = 0.041) [28]. Here, XRCC1 is linked to head and neck squamous cell carcinoma.